Skip to main content

Advertisement

SpringerLink
Log in

Understanding STAT3 signaling in cardiac ischemia

  • Review
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

Cardiovascular disease is the leading cause of death worldwide. It remains one of the greatest challenges to global health and will continue to dominate mortality trends in the future. Acute myocardial infarction results in 7.4 million deaths globally per annum. Current management strategies are centered on restoration of coronary blood flow via percutaneous coronary intervention, coronary artery bypass grafting and administration of anti-platelet agents. Such myocardial reperfusion accounts for 40–50 % of the final infarct size in most cases. Signaling transducer and activator of transcription 3 (STAT3) has been shown to have cardioprotective effects via canonical and non-canonical activation and modulation of mitochondrial and transcriptional responses. A significant body of in vitro and in vivo evidence suggests that activation of the STAT3 signal transduction pathway results in a cardio protective response to ischemia and attempts have been made to modulate this with therapeutic effect. Not only is STAT3 important for cardiomyocyte function, but it also modulates the cardiac microenvironment and communicates with cardiac fibroblasts. To this end, we here review the current evidence supporting the manipulation of STAT3 for therapeutic benefit in cardiac ischemia and identify areas for future research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Institute of Medicine (US) (2010) Committee on preventing the global epidemic of cardiovascular disease: meeting the challenges in developing countries. In: Fuster V, Kelly BB (eds) Promoting cardiovascular health in the developing world; a critical challenge to achieve global health. National Academies Press, Washington, DC

  2. Baker JE, Su J, Hsu A, Shi Y, Zhao M, Strande JL, Fu X, Xu H, Eis A, Komorowski R, Jensen ES, Tweddell JS, Rafiee P, Gross GJ (2008) Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats. Cardiovasc Res 77:44–53. doi:10.1093/cvr/cvm026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Becker S, Groner B, Muller CW (1998) Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 394:145–151. doi:10.1038/28101

    Article  CAS  PubMed  Google Scholar 

  4. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R (2008) Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 102:131–135. doi:10.1161/CIRCRESAHA.107.164699

    Article  CAS  PubMed  Google Scholar 

  5. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R (2008) The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 120:172–185. doi:10.1016/j.pharmthera.2008.08.002

    Article  CAS  PubMed  Google Scholar 

  6. Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G et al (2008) Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 102(1):131–135. doi:10.1152/ajpheart.00692.2008

    Article  CAS  PubMed  Google Scholar 

  7. Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R (2010) Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 105:771–785. doi:10.1007/s00395-010-0124-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Boengler K, Ungefug E, Heusch G, Schulz R (2013) The STAT3 inhibitor stattic impairs cardiomyocyte mitochondrial function through increased reactive oxygen species formation. Curr Phar Des 19:6890–6895. doi:10.2174/138161281939131127115940

    Article  CAS  Google Scholar 

  9. Booz GW, Day JN, Baker KM (2002) Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 34:1443–1453. doi:10.1006/jmcc.2002.2076

    Article  CAS  PubMed  Google Scholar 

  10. Brulhart-Meynet MC, Braunersreuther V, Brinck J, Montecucco F, Prost JC, Thomas A, Galan K, Pelli G, Pedretti S, Vuilleumier N, Mach F, Lecour S, James RW, Frias MA (2015) Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury. PLoS One 10:e0119664. doi:10.1371/journal.pone.0119664

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A, Frangogiannis NG (2008) Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Path 173:57–67. doi:10.2353/ajpath.2008.070974

    Article  PubMed  PubMed Central  Google Scholar 

  12. Butler KL, Huffman LC, Koch SE, Hahn HS, Gwathmey JK (2006) STAT-3 activation is necessary for ischemic pre-conditioning in hypertrophied myocardium. Am J Physiol Heart Circ Physiol 291:H797–H803. doi:10.1152/ajpheart.01334.2005

    Article  CAS  PubMed  Google Scholar 

  13. Byrne MJ, Power JM, Preovolos A, Mariani JA, Hajjar RJ, Kaye DM (2008) Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. Gene Ther 15:1550–1557. doi:10.1038/gt.2008.120

    Article  CAS  PubMed  Google Scholar 

  14. Chatterjee S, Stewart AS, Bish LT, Jayasankar V, Kim EM, Pirolli T, Burdick J, Woo YJ, Gardner TJ, Sweeney HL (2002) Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure. Circulation 106:I212–I217. doi:10.1161/01.cir.0000032907.33237.55

    PubMed  Google Scholar 

  15. Chung CD, Liao J, Liu B, Rao X, Jay P, Berta P, Shuai K (1997) Specific inhibition of Stat3 signal transduction by PIAS3. Science 278:1803–1805. doi:10.1126/science.278.5344.1803

    Article  CAS  PubMed  Google Scholar 

  16. Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421. doi:10.1126/science.8197455

    Article  CAS  PubMed  Google Scholar 

  17. Das A, Salloum FN, Durrant D, Ockaili R, Kukreja RC (2012) Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. J Mol Cell Cardiol 53:858–869. doi:10.1016/j.yjmcc.2012.09.007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Dawn B, Xuan YT, Guo Y, Rezazadeh A, Stein AB, Hunt G, Wu WJ, Tan W, Bolli R (2004) IL-6 plays an obligatory role in late pre-conditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 64:61–71. doi:10.1016/j.cardiores.2004.05.011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Deten A, Volz HC, Briest W, Zimmer HG (2003) Differential cytokine expression in myocytes and non-myocytes after myocardial infarction in rats. Mol Cell Biochem 242:47–55. doi:10.1023/A:1021129410221

    Article  CAS  PubMed  Google Scholar 

  20. Duan W, Yang Y, Yan J, Yu S, Liu J, Zhou J, Zhang J, Jin Z, Yi D (2012) The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway. Basic Res Cardiol 107:263. doi:10.1007/s00395-012-0263-7

    Article  PubMed  CAS  Google Scholar 

  21. Ferreira R (2010) The reduction of infarct size–forty years of research. Rev Port Cardiol 29:1037–1053. doi:10.1590/1414-431X20132999

    PubMed  Google Scholar 

  22. Fischer P, Hilfiker-Kleiner D (2007) Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis. Basic Res Cardiol 102:279–297. doi:10.1007/s00395-007-0658-z

    Article  CAS  PubMed  Google Scholar 

  23. Frangogiannis NG, Perrard JL, Mendoza LH, Burns AR, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML (1998) Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 98:687–698. doi:10.1161/01.CIR.98.7.687

    Article  CAS  PubMed  Google Scholar 

  24. Freed DH, Moon MC, Borowiec AM, Jones SC, Zahradka P, Dixon IM (2003) Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing. Mol Cell Biol 254:247–256. doi:10.1023/A:1027332504861

    CAS  Google Scholar 

  25. Frias MA, Pedretti S, Hacking D, Somers S, Lacerda L, Opie LH, James RW, Lecour S (2013) HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity. Atherosclerosis 228:110–116. doi:10.1016/j.atherosclerosis.2013.02.003

    Article  CAS  PubMed  Google Scholar 

  26. Fuchs M, Hilfiker A, Kaminski K, Hilfiker-Kleiner D, Guener Z, Klein G, Podewski E, Schieffer B, Rose-John S, Drexler H (2003) Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction. FASEB J 17:2118–2120. doi:10.1096/fj.03-0331fje

    CAS  PubMed  Google Scholar 

  27. Fuglesteg BN, Suleman N, Tiron C, Kanhema T, Lacerda L, Andreasen TV, Sack MN, Jonassen AK, Mjos OD, Opie LH, Lecour S (2008) Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Res Cardiol 103:444–453. doi:10.1007/s00395-008-0728-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Gross ER, Hsu AK, Gross GJ (2006) The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Am J Physiol 291:H827–H834. doi:10.1152/ajpheart.00003.2006

    CAS  Google Scholar 

  29. Guo W, Liu H, Li L, Yang M, Du A (2014) Regulation of lovastatin on a key inflammation-related microRNA in myocardial cells. Chin Med J 127:2977–2981. doi:10.3760/cma.j.issn.0366-6999.20140780

    PubMed  Google Scholar 

  30. Haghikia A, Missol-Kolka E, Tsikas D, Venturini L, Brundiers S, Castoldi M, Muckenthaler MU, Eder M, Stapel B, Thum T, Haghikia A, Petrasch-Parwez E, Drexler H, Hilfiker-Kleiner D, Scherr M (2011) Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J 32:1287–1297. doi:10.1093/eurheartj/ehq369

    Article  CAS  PubMed  Google Scholar 

  31. Haghikia A, Stapel B, Hoch M, Hilfiker-Kleiner D (2011) STAT3 and cardiac remodeling. Heart Fail Rev 16:35–47. doi:10.1007/s10741-010-9170-x

    Article  CAS  PubMed  Google Scholar 

  32. Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, Ohtsuka M, Matsuura K, Sano M, Nishi J, Iwanaga K, Akazawa H, Kunieda T, Zhu W, Hasegawa H, Kunisada K, Nagai T, Nakaya H, Yamauchi-Takihara K, Komuro I (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nature Med 11:305–311. doi:10.1038/nm1199

    Article  CAS  PubMed  Google Scholar 

  33. Hattori R, Maulik N, Otani H, Zhu L, Cordis G, Engelman RM, Siddiqui MA, Das DK (2001) Role of STAT3 in ischemic pre-conditioning. J Mol Cell Cardiol 33:1929–1936. doi:10.1006/jmcc.2001.1456

    Article  CAS  PubMed  Google Scholar 

  34. Hausenloy DJ, Lecour S, Yellon DM (2011) Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14:893–907. doi:10.1089/ars.2010.3360

    Article  CAS  PubMed  Google Scholar 

  35. Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166–175. doi:10.1016/S0140-6736(12)60916-7

    Article  PubMed  Google Scholar 

  36. Heusch G (2015) Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning. Circ Res 116:674–699. doi:10.1161/CIRCRESAHA.116.305348

    Article  CAS  PubMed  Google Scholar 

  37. Heusch G, Musiolik J, Gedik N, Skyschally A (2011) Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 109:1302–1308. doi:10.1161/CIRCRESAHA.111.255604

    Article  CAS  PubMed  Google Scholar 

  38. Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M (2012) STAT5 activation and cardioprotection by remote ischemic pre-conditioning in humans: short communication. Circ Res 110:111–115. doi:10.1161/CIRCRESAHA.111.259556

    Article  CAS  PubMed  Google Scholar 

  39. Hilfiker-Kleiner D, Hilfiker A, Fuchs M, Kaminski K, Schaefer A, Schieffer B, Hillmer A, Schmiedl A, Ding Z, Podewski E, Podewski E, Poli V, Schneider MD, Schulz R, Park JK, Wollert KC, Drexler H (2004) Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res 95:187–195. doi:10.1161/01.RES.0000134921.50377.61

    Article  CAS  PubMed  Google Scholar 

  40. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K et al (2007) A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128(3):589–600. doi:10.1016/j.cell.2006.12.036

    Article  CAS  PubMed  Google Scholar 

  41. Hilfiker-Kleiner D, Shukla P, Klein G, Schaefer A, Stapel B, Hoch M, Muller W, Scherr M, Theilmeier G, Ernst M, Hilfiker A, Drexler H (2010) Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction. Circulation 122:145–155. doi:10.1161/CIRCULATIONAHA.109.933127

    Article  CAS  PubMed  Google Scholar 

  42. Hoch M, Fischer P, Stapel B, Missol-Kolka E, Sekkali B, Scherr M, Favret F, Braun T, Eder M, Schuster-Gossler K, Gossler A, Hilfiker A, Balligand JL, Drexler H, Hilfiker-Kleiner D (2011) Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies. Cell Stem Cell 9:131–143. doi:10.1016/j.stem.2011.07.001

    Article  CAS  PubMed  Google Scholar 

  43. Huffman LC, Koch SE, Butler KL (2008) Coronary effluent from a preconditioned heart activates the JAK-STAT pathway and induces cardioprotection in a donor heart. American journal of physiology. Heart Circ Physiol 294:H257–H262. doi:10.1152/ajpheart.00769.2007

    Article  CAS  Google Scholar 

  44. Jacoby JJ, Kalinowski A, Liu MG, Zhang SS, Gao Q, Chai GX, Ji L, Iwamoto Y, Li E, Schneider M, Russell KS, Fu XY (2003) Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proc Natl Acad Sci USA 100:12929–12934. doi:10.1073/pnas.2134694100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ, Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease I (2011) Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124:304–313. doi:10.1161/CIRCULATIONAHA.111.022889

    Article  CAS  PubMed  Google Scholar 

  46. Jiang HM, Wang HX, Yang H, Zeng XJ, Tang CS, Du J, Li HH (2013) Role for granulocyte colony stimulating factor in angiotensin II-induced neutrophil recruitment and cardiac fibrosis in mice. Am J Hypertens 26:1224–1233. doi:10.1093/ajh/hpt095

    Article  CAS  PubMed  Google Scholar 

  47. Katoh M, Katoh M (2007) STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review). Int J Mol Med 19:273–278. doi:10.3892/ijmm.19.2.273

    CAS  PubMed  Google Scholar 

  48. Kawaguchi M, Kataoka H (2014) Mechanisms of hepatocyte growth factor activation in cancer tissues. Cancers 6:1890–1904. doi:10.3390/cancers6041890

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Kelly RF, Lamont KT, Somers S, Hacking D, Lacerda L, Thomas P, Opie LH, Lecour S (2010) Ethanolamine is a novel STAT-3 dependent cardioprotective agent. Basic Res Cardiol 105:763–770. doi:10.1007/s00395-010-0125-0

    Article  CAS  PubMed  Google Scholar 

  50. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW (2002) Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285:1–24. doi:10.1016/S0378-1119(02)00398-0

    Article  CAS  PubMed  Google Scholar 

  51. Kiu H, Nicholson SE (2012) Biology and significance of the JAK/STAT signalling pathways. Growth Factors 30:88–106. doi:10.3109/08977194.2012.660936

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Kodama H, Fukuda K, Pan J, Makino S, Sano M, Takahashi T, Hori S, Ogawa S (1998) Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes. Circ Res 82:244–250. doi:10.1161/01.RES.82.2.244

    Article  CAS  PubMed  Google Scholar 

  53. Krishnamurthy P, Thal M, Verma S, Hoxha E, Lambers E, Ramirez V, Qin G, Losordo D, Kishore R (2011) Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res 109:1280–1289. doi:10.1161/CIRCRESAHA.111.248369

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, Kishimoto T (1998) Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98:346–352. doi:10.1161/01.CIR.98.4.346

    Article  CAS  PubMed  Google Scholar 

  55. Kurdi M, Booz GW (2007) Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling. J Cardiovasc Pharm 50:126–141. doi:10.1097/FJC.0b013e318068dd49

    Article  CAS  Google Scholar 

  56. Kurdi M, Booz GW (2010) Deciphering STAT3 signaling in the heart: plasticity and vascular inflammation. Congest Heart Fail 16:234–238. doi:10.1111/j.1751-7133.2010.00175.x

    Article  PubMed  PubMed Central  Google Scholar 

  57. Lacerda L, Somers S, Opie LH, Lecour S (2009) Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 84:201–208. doi:10.1093/cvr/cvp274

    Article  CAS  PubMed  Google Scholar 

  58. Lamont KT, Somers S, Lacerda L, Opie LH, Lecour S (2011) Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection. J Pin Res 50:374–380. doi:10.1111/j.1600-079X.2010.00853.x

    Article  CAS  Google Scholar 

  59. Lecour S, James RW (2011) When are pro-inflammatory cytokines SAFE in heart failure? Eur Heart J 32:680–685. doi:10.1093/eurheartj/ehq484

    Article  CAS  PubMed  Google Scholar 

  60. Lecour S, Suleman N, Deuchar GA, Somers S, Lacerda L, Huisamen B, Opie LH (2005) Pharmacological pre-conditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase). Circulation 112:3911–3918. doi:10.1161/CIRCULATIONAHA.105.581058

    Article  CAS  PubMed  Google Scholar 

  61. Li Y, Zhu W, Tao J, Xin P, Liu M, Li J, Wei M (2012) Fasudil protects the heart against ischemia-reperfusion injury by attenuating endoplasmic reticulum stress and modulating SERCA activity: the differential role for PI3K/Akt and JAK2/STAT3 signaling pathways. PLoS One 7:e48115. doi:10.1371/journal.pone.0048115

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Lim CP, Cao X (2006) Structure, function, and regulation of STAT proteins. Mol BioSyst 2:536–550. doi:10.1039/b606246f

    Article  CAS  PubMed  Google Scholar 

  63. Liu Y, Yang H, Song L, Li N, Han QY, Tian C, Gao E, Du J, Xia YL, Li HH (2014) AGGF1 protects from myocardial ischemia/reperfusion injury by regulating myocardial apoptosis and angiogenesis. Apoptosis 19:1254–1268. doi:10.1007/s10495-014-1001-4

    Article  CAS  PubMed  Google Scholar 

  64. Lorchner H, Poling J, Gajawada P, Hou Y, Polyakova V, Kostin S, Adrian-Segarra JM, Boettger T, Wietelmann A, Warnecke H, Richter M, Kubin T, Braun T (2015) Myocardial healing requires Reg3beta-dependent accumulation of macrophages in the ischemic heart. Nature Med 21:353–362. doi:10.1038/nm.3816

    Article  PubMed  CAS  Google Scholar 

  65. Ma Y, Yuan X, Deng L, Xu W, Zheng Y, Yue C, Zhang G, Xie F, Yang YH, Gantier MP, Liu J, Xu D, Shen L (2013) Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling. PLoS One 8:e72804. doi:10.1371/journal.pone.0072804

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Macchi L, Moussa WB, Guillou S, Tamareille S, Lamon D, Prunier D, Prunier F (2014) The synthetic pentasaccharide fondaparinux attenuates myocardial ischemia-reperfusion injury in rats via STAT-3. Shock 41:166–171. doi:10.1097/SHK.0000000000000072

    Article  CAS  PubMed  Google Scholar 

  67. Mao X, Ren Z, Parker GN, Sondermann H, Pastorello MA, Wang W, McMurray JS, Demeler B, Darnell JE Jr, Chen X (2005) Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell 17:761–771. doi:10.1016/j.molcel.2005.02.021

    Article  CAS  PubMed  Google Scholar 

  68. McCormick J, Suleman N, Scarabelli TM, Knight RA, Latchman DS, Stephanou A (2012) STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy. J Cell Mol Med 16:386–393. doi:10.1111/j.1582-4934.2011.01323.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. McGaffin KR, Sun CK, Rager JJ, Romano LC, Zou B, Mathier MA, O’Doherty RM, McTiernan CF, O’Donnell CP (2008) Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc Res 77:54–63. doi:10.1093/cvr/cvm023

    Article  CAS  PubMed  Google Scholar 

  70. Melendez GC, McLarty JL, Levick SP, Du Y, Janicki JS, Brower GL (2010) Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56:225–231. doi:10.1161/HYPERTENSIONAHA.109.148635

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Mewton N, Elbaz M, Piot C, Ovize M (2011) Infarct size reduction in patients with STEMI: why we can do it! J Cardiovasc Pharm Ther 16:298–303. doi:10.1177/1074248411412379

    Article  Google Scholar 

  72. Mohri T, Fujio Y, Obana M, Iwakura T, Matsuda K, Maeda M, Azuma J (2009) Signals through glycoprotein 130 regulate the endothelial differentiation of cardiac stem cells. Arterioscl Thromb Vasc Biol 29:754–760. doi:10.1161/ATVBAHA.108.174870

    Article  CAS  PubMed  Google Scholar 

  73. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, Naghavi M (2014) Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation 129:1483–1492. doi:10.1161/CIRCULATIONAHA.113.004042

    Article  PubMed  PubMed Central  Google Scholar 

  74. Nagata T, Yasukawa H, Kyogoku S, Oba T, Takahashi J, Nohara S, Minami T, Mawatari K, Sugi Y, Shimozono K, Pradervand S, Hoshijima M, Aoki H, Fukumoto Y, Imaizumi T (2015) Cardiac-specific SOCS3 deletion prevents in vivo myocardial ischemia reperfusion injury through sustained activation of cardioprotective signaling molecules. PLoS One 10:e0127942. doi:10.1371/journal.pone.0127942

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  75. Negoro S, Kunisada K, Tone E, Funamoto M, Oh H, Kishimoto T, Yamauchi-Takihara K (2000) Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction. Cardiovasc Res 47:797–805. doi:10.1016/S0008-6363(00)00138-3

    Article  CAS  PubMed  Google Scholar 

  76. Obana M, Maeda M, Takeda K, Hayama A, Mohri T, Yamashita T, Nakaoka Y, Komuro I, Takeda K, Matsumiya G, Azuma J, Fujio Y (2010) Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction. Circulation 121:684–691. doi:10.1161/CIRCULATIONAHA.109.893677

    Article  CAS  PubMed  Google Scholar 

  77. Oh H, Fujio Y, Kunisada K, Hirota H, Matsui H, Kishimoto T, Yamauchi-Takihara K (1998) Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes. J Biol Chem 273(16):9703–9710. doi:10.1074/jbc.273.16.9703

    Article  CAS  PubMed  Google Scholar 

  78. Omura T, Yoshiyama M, Ishikura F, Kobayashi H, Takeuchi K, Beppu S, Yoshikawa J (2001) Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. J Mol Cell Cardiol 33:307–316. doi:10.1006/jmcc.2000.1303

    Article  CAS  PubMed  Google Scholar 

  79. Organisation WH (2015) Factsheet on cardiovascular diseases. factsheet No 317

  80. Oshima Y, Fujio Y, Nakanishi T, Itoh N, Yamamoto Y, Negoro S, Tanaka K, Kishimoto T, Kawase I, Azuma J (2005) STAT3 mediates cardioprotection against ischemia/reperfusion injury through metallothionein induction in the heart. Cardiovasc Res 65:428–435. doi:10.1016/j.cardiores.2004.10.021

    Article  CAS  PubMed  Google Scholar 

  81. Prigge JR, Schmidt EE (2006) Interaction of protein inhibitor of activated STAT (PIAS) proteins with the TATA-binding protein, TBP. J Biol Chem 281:12260–12269. doi:10.1074/jbc.M510835200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Rafiee P, Shi Y, Su J, Pritchard KA Jr, Tweddell JS, Baker JE (2005) Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol 100:187–197. doi:10.1007/s00395-004-0508-1

    Article  CAS  PubMed  Google Scholar 

  83. Ramchandani D, Weber GF (2015) Interactions between Osteopontin vascular endothelial growth factor: implications for cancer. Biochim Biophys Acta. doi:10.1016/j.bbcan.2015.02.003

    PubMed  Google Scholar 

  84. Ricke-Hoch M, Bultmann I, Stapel B, Condorelli G, Rinas U, Sliwa K, Scherr M, Hilfiker-Kleiner D (2014) Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress. Cardiovasc Res 101:587–596. doi:10.1093/cvr/cvu010

    Article  PubMed  Google Scholar 

  85. Salisbury TB, Tomblin JK (2015) Insulin/Insulin-like growth factors in cancer: new roles for the aryl hydrocarbon receptor, tumor resistance mechanisms, and new blocking strategies. Front Endocrinol 6:12. doi:10.3389/fendo.2015.00012

    Google Scholar 

  86. Schindler C, Darnell JE Jr (1995) Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem 64:621–651. doi:10.1146/annurev.bi.64.070195.003201

    Article  CAS  PubMed  Google Scholar 

  87. Schindler C, Levy DE, Decker T (2007) JAK-STAT signaling: from interferons to cytokines. J Biol Chem 282:20059–20063. doi:10.1074/jbc.R700016200

    Article  CAS  PubMed  Google Scholar 

  88. Schuringa JJ, Schepers H, Vellenga E, Kruijer W (2001) Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Lett 495:71–76. doi:10.1016/S0014-5793(01)02354-7

    Article  CAS  PubMed  Google Scholar 

  89. Shravah J, Wang B, Pavlovic M, Kumar U, Chen DD, Luo H, Ansley DM (2014) Propofol mediates signal transducer and activator of transcription 3 activation and crosstalk with phosphoinositide 3-kinase/AKT. Jak-Stat 3:e29554. doi:10.4161/jkst.29554

    Article  PubMed  PubMed Central  Google Scholar 

  90. Skyschally A, Gent S, Amanakis G, Schulte C, Kleinbongard P, Heusch G (2015) Across-species transfer of protection by remote ischemic pre-conditioning with species-specific myocardial signal transduction by RISK and SAFE Pathways. Circ Res. doi:10.1161/CIRCRESAHA.117.306878

    PubMed  Google Scholar 

  91. Smith RM, Suleman N, Lacerda L, Opie LH, Akira S, Chien KR, Sack MN (2004) Genetic depletion of cardiac myocyte STAT-3 abolishes classical pre-conditioning. Cardiovasc Res 63:611–616. doi:10.1016/j.cardiores.2004.06.019

    Article  CAS  PubMed  Google Scholar 

  92. Somers SJ, Frias M, Lacerda L, Opie LH, Lecour S (2012) Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc Drugs Ther 26:227–237. doi:10.1007/s10557-012-6376-2

    Article  CAS  PubMed  Google Scholar 

  93. Somers SJ, Frias M, Lacerda L, Opie LH, Lecour S (2012) Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection. Cardiovasc Drugs Ther. doi:10.1007/s10557-012-6376-2

    PubMed  Google Scholar 

  94. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227–264. doi:10.1146/annurev.biochem.67.1.227

    Article  CAS  PubMed  Google Scholar 

  95. Starr R, Hilton DJ (1999) Negative regulation of the JAK/STAT pathway. BioEssays 21:47–52. doi:10.1002/(SICI)1521-1878(199901)21:1<47:AID-BIES6>3.0.CO;2-N

    Article  CAS  PubMed  Google Scholar 

  96. Szczepanek K, Chen Q, Derecka M, Salloum FN, Zhang Q, Szelag M, Cichy J, Kukreja RC, Dulak J, Lesnefsky EJ, Larner AC (2011) Mitochondrial-targeted Signal transducer and activator of transcription 3 (STAT3) protects against ischemia-induced changes in the electron transport chain and the generation of reactive oxygen species. J Biol Chem 286:29610–29620. doi:10.1074/jbc.M111.226209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Szczepanek K, Chen Q, Larner AC, Lesnefsky EJ (2012) Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3. Mitochondrion 12:180–189. doi:10.1016/j.mito.2011.08.011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG, Zhang X, Korostyshevskiy VR, Cheema A, Zhang L, Dakshanamurthy S, Brown ML, Dritschilo A (2012) Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem 287:14192–14200. doi:10.1074/jbc.M111.323899

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Wang Y, Yin B, Liu S, Xue S (2007) Cardioprotective effect by tumor necrosis factor-alpha and interleukin-6 through late preconditioning in unstable angina patients. Arch Med Res 38(1):80–85. doi:10.1016/j.arcmed.2006.07.006

    Article  CAS  PubMed  Google Scholar 

  100. Wang M, Zhang W, Crisostomo P, Markel T, Meldrum KK, Fu XY et al (2007) Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling. Am J Physiol Heart Circ Physiol 293(4):H2101–H2108. doi:10.1152/ajpheart.00125.2007

    Article  CAS  PubMed  Google Scholar 

  101. Wang W, Kagaya Y, Asaumi Y, Fukui S, Takeda M, Shimokawa H (2011) Protective effects of recombinant human erythropoietin against pressure overload-induced left ventricular remodeling and premature death in mice. Tohoku J Exp Med 225:131–143. doi:10.1620/tjem.225.131

    Article  CAS  PubMed  Google Scholar 

  102. Wang X, Crowe PJ, Goldstein D, Yang JL (2012) STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (review). Int J Onc 41:1181–1191. doi:10.3892/ijo.2012.1568

    CAS  Google Scholar 

  103. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, Moh A, Moghaddas S, Chen Q, Bobbili S, Cichy J, Dulak J, Baker DP, Wolfman A, Stuehr D, Hassan MO, Fu XY, Avadhani N, Drake JI, Fawcett P, Lesnefsky EJ, Larner AC (2009) Function of mitochondrial Stat3 in cellular respiration. Science 323:793–797. doi:10.1126/science.1164551

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Williams TM, Waksman R, De Silva K, Jacques A, Mahmoudi M (2014) Ischemic pre-conditioning-an unfulfilled promise. Cardiovasc Revasc Med. doi:10.1016/j.carrev.2014.12.010

    PubMed  Google Scholar 

  105. Wu L, Tan JL, Wang ZH, Chen YX, Gao L, Liu JL, Shi YH, Endoh M, Yang HT (2015) ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway. J Mol Cell Cardiol 81:150–161. doi:10.1016/j.yjmcc.2015.02.015

    Article  CAS  PubMed  Google Scholar 

  106. Xu X, Sun YL, Hoey T (1996) Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 273:794–797. doi:10.1126/science.273.5276.794

    Article  CAS  PubMed  Google Scholar 

  107. Xuan YT, Guo Y, Han H, Zhu Y, Bolli R (2001) An essential role of the JAK-STAT pathway in ischemic pre-conditioning. Proc Natl Acad Sci USA 98:9050–9055. doi:10.1073/pnas.161283798

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Yamada Y, Kobayashi H, Iwasa M, Sumi S, Ushikoshi H, Aoyama T, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Kiso M, Minatoguchi S (2013) Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits. Am J Physiol 304:H1124–H1133. doi:10.1152/ajpheart.00707.2012

    CAS  Google Scholar 

  109. Yamauchi-Takihara K, Kishimoto T (2000) A novel role for STAT3 in cardiac remodeling. Trends Cardiovasc Med 10:298–303. doi:10.1016/S1050-1738(01)00066-4

    Article  CAS  PubMed  Google Scholar 

  110. Yasukawa H, Hoshijima M, Gu Y, Nakamura T, Pradervand S, Hanada T, Hanakawa Y, Yoshimura A, Ross J Jr, Chien KR (2001) Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways. J Clin Invest 108:1459–1467. doi:10.1172/JCI13939

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Yeghiazarians Y, Khan M, Angeli FS, Zhang Y, Jahn S, Prasad M, Mirsky R, Shih H, Minasi P, Boyle A, Grossman W (2010) Cytokine combination therapy with long-acting erythropoietin and granulocyte colony stimulating factor improves cardiac function but is not superior than monotherapy in a mouse model of acute myocardial infarction. J Card Fail 16:669–678. doi:10.1016/j.cardfail.2010.03.008

    Article  CAS  PubMed  Google Scholar 

  112. Yu H, Jove R (2004) The STATs of cancer–new molecular targets come of age. Nat Rev Cancer 4:97–105. doi:10.1038/nrc1275

    Article  CAS  PubMed  Google Scholar 

  113. Zouein FA, Duhe RJ, Arany I, Shirey K, Hosler JP, Liu H, Saad I, Kurdi M, Booz GW (2014) Loss of STAT3 in mouse embryonic fibroblasts reveals its Janus-like actions on mitochondrial function and cell viability. Cytokine 66:7–16. doi:10.1016/j.cyto.2013.12.006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Zouein FA, Kurdi M, Booz GW (2013) Dancing rhinos in stilettos: the amazing saga of the genomic and nongenomic actions of STAT3 in the heart. Jak-Stat 2:e24352. doi:10.4161/jkst.24352

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Mater Private Hospital, Eccles St, Dublin 7, Ireland

    K. E. O’Sullivan, E. P. Breen, D. J. Buggy & J. P. Hurley

  2. School of Medicine and Medical Science, University College Dublin, Belfield, Dublin 4, Ireland

    H. C. Gallagher & D. J. Buggy

  3. Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland

    H. C. Gallagher & D. J. Buggy

  4. UCD-Mater Clinical Research Centre, Catherine McCauley Centre, Nelson St, Dublin 7, Ireland

    H. C. Gallagher & D. J. Buggy

  5. Outcomes Research Consortium, Cleveland Clinic, Ohio, USA

    D. J. Buggy

Authors
  1. K. E. O’Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. P. Breen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. C. Gallagher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. J. Buggy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. P. Hurley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. E. O’Sullivan.

Ethics declarations

Conflict of interest

There are no conflicts of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Sullivan, K.E., Breen, E.P., Gallagher, H.C. et al. Understanding STAT3 signaling in cardiac ischemia. Basic Res Cardiol 111, 27 (2016). https://doi.org/10.1007/s00395-016-0543-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00395-016-0543-8

Keywords

Search

Navigation